Cargando…
Integrating plasma cell‐free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID‐19 at hospital admission
Autores principales: | Bai, Yong, Zheng, Fang, Zhang, Tongda, Luo, Qiuhong, Luo, Yuxue, Zhou, Ruilong, Jin, Yan, Shan, Ying, Cheng, Jiehui, Yang, Zhimin, Li, Lingguo, Zhang, Haiqiang, Zhang, Yan, Yin, Jianhua, Fang, Mingyan, Chen, Dongsheng, Cheng, Fanjun, Jin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286531/ https://www.ncbi.nlm.nih.gov/pubmed/35839327 http://dx.doi.org/10.1002/ctm2.966 |
Ejemplares similares
-
Rare Variants in Inborn Errors of Immunity Genes Associated With Covid-19 Severity
por: Liu, Panhong, et al.
Publicado: (2022) -
Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients
por: Chen, Xinping, et al.
Publicado: (2021) -
deepMNN: Deep Learning-Based Single-Cell RNA Sequencing Data Batch Correction Using Mutual Nearest Neighbors
por: Zou, Bin, et al.
Publicado: (2021) -
A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity
por: Zhu, Huanhuan, et al.
Publicado: (2021) -
The fragmentomic property of plasma cell-free DNA enables the non-invasive detection of diabetic nephropathy in patients with diabetes mellitus
por: Yu, Chaolun, et al.
Publicado: (2023)